Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.

Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA.

Tissue Antigens. 2007 Dec;70(6):480-6. Epub 2007 Oct 8.

PMID:
17927685
2.

Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.

Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.

J Immunol. 2003 Dec 15;171(12):6910-8.

3.

Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.

Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.

J Immunol. 1999 Aug 1;163(3):1647-53.

4.

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.

McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A.

Am J Ind Med. 2004 Aug;46(2):95-103.

PMID:
15273960
5.

Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.

Gaede KI, Amicosante M, Schürmann M, Fireman E, Saltini C, Müller-Quernheim J.

J Mol Med (Berl). 2005 May;83(5):397-405. Epub 2005 Mar 5.

PMID:
15750822
6.

Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.

Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1680-8. doi: 10.1164/rccm.201002-0254OC. Epub 2011 Mar 11.

7.

Beryllium sensitivity is linked to HLA-DP genotype.

Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL.

Toxicology. 2001 Aug 13;165(1):27-38.

PMID:
11551429
8.

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.

Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA.

J Immunol. 2012 Oct 15;189(8):4014-23. doi: 10.4049/jimmunol.1200798. Epub 2012 Sep 12.

9.

Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles.

Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, Asukata Y, Takeuchi M, Ito N, Shibuya E, Nomura E, Uemoto R, Nishide T, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Nakamura J, Saeki K, Ohno S, Inoko H, Mizuki N.

Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7109-15. doi: 10.1167/iovs.12-10491.

PMID:
22991420
10.

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.

Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.

Occup Environ Med. 2011 Jul;68(7):487-93. doi: 10.1136/oem.2010.055046. Epub 2010 Dec 23. Review.

PMID:
21186201
11.

Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.

Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, Wells AU, Tzouvelekis A, van Moorsel CH, van den Bosch JM, du Bois RM, Welsh KI.

Tissue Antigens. 2007 Sep;70(3):219-27.

PMID:
17661910
12.

Genetic determinants of sensitivity to beryllium in mice.

Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.

J Immunotoxicol. 2009 Jun;6(2):130-5. doi: 10.1080/15476910902977399.

PMID:
19589099
13.

HLA-DPB1 and chronic beryllium disease: a HuGE review.

McCanlies EC, Kreiss K, Andrew M, Weston A.

Am J Epidemiol. 2003 Mar 1;157(5):388-98. Review.

PMID:
12615603
14.

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Richeldi L, Sorrentino R, Saltini C.

Science. 1993 Oct 8;262(5131):242-4.

PMID:
8105536
15.

Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502.

Mochida A, Kinouchi Y, Negoro K, Takahashi S, Takagi S, Nomura E, Kakuta Y, Tosa M, Shimosegawa T.

Tissue Antigens. 2007 Aug;70(2):128-35.

PMID:
17610417
16.

Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis.

Maliarik MJ, Chen KM, Major ML, Sheffer RG, Popovich J Jr, Rybicki BA, Iannuzzi MC.

Am J Respir Crit Care Med. 1998 Jul;158(1):111-4.

PMID:
9655715
17.

Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.

Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP.

J Immunol. 2005 Nov 15;175(10):7029-37.

18.

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.

Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):788-94.

PMID:
11897645
19.
20.

High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease.

Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff E, Rose CS, Newman LS.

Am J Respir Crit Care Med. 2001 Oct 1;164(7):1192-9.

PMID:
11673208

Supplemental Content

Support Center